Genmab AS Pink Sheet Forecast - Polynomial Regression
| GNMSF Stock | USD 212.50 4.81 2.32% |
The Polynomial Regression forecasted value of Genmab AS on the next trading day is expected to be 201.07 with a mean absolute deviation of 5.00 and the sum of the absolute errors of 304.75. Genmab Pink Sheet Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Genmab AS's historical fundamentals, such as revenue growth or operating cash flow patterns.
Genmab |
Genmab AS Polynomial Regression Price Forecast For the 1st of December
Given 90 days horizon, the Polynomial Regression forecasted value of Genmab AS on the next trading day is expected to be 201.07 with a mean absolute deviation of 5.00, mean absolute percentage error of 37.80, and the sum of the absolute errors of 304.75.Please note that although there have been many attempts to predict Genmab Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Genmab AS's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Genmab AS Pink Sheet Forecast Pattern
| Backtest Genmab AS | Genmab AS Price Prediction | Buy or Sell Advice |
Genmab AS Forecasted Value
In the context of forecasting Genmab AS's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Genmab AS's downside and upside margins for the forecasting period are 198.14 and 204.00, respectively. We have considered Genmab AS's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of Genmab AS pink sheet data series using in forecasting. Note that when a statistical model is used to represent Genmab AS pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 121.7427 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 4.996 |
| MAPE | Mean absolute percentage error | 0.0218 |
| SAE | Sum of the absolute errors | 304.754 |
Predictive Modules for Genmab AS
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Genmab AS. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Genmab AS's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for Genmab AS
For every potential investor in Genmab, whether a beginner or expert, Genmab AS's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Genmab Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Genmab. Basic forecasting techniques help filter out the noise by identifying Genmab AS's price trends.View Genmab AS Related Equities
| Risk & Return | Correlation |
Genmab AS Technical and Predictive Analytics
The pink sheet market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Genmab AS's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Genmab AS's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Genmab AS Market Strength Events
Market strength indicators help investors to evaluate how Genmab AS pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Genmab AS shares will generate the highest return on investment. By undertsting and applying Genmab AS pink sheet market strength indicators, traders can identify Genmab AS entry and exit signals to maximize returns.
Genmab AS Risk Indicators
The analysis of Genmab AS's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Genmab AS's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting genmab pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.3 | |||
| Standard Deviation | 2.89 | |||
| Variance | 8.33 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Genmab Pink Sheet
When determining whether Genmab AS offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Genmab AS's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Genmab As Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Genmab As Stock:Check out Historical Fundamental Analysis of Genmab AS to cross-verify your projections. For more detail on how to invest in Genmab Pink Sheet please use our How to Invest in Genmab AS guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.